MONTREAL, April 26, 2012 /CNW Telbec/ - Sanofi Canada is supporting a five-year study on radiation therapy and prostate cancer. Dr. Tamim Niazi (centre left), of the Quebec Radiation Oncology GU Group and the JGH, is the lead researcher. Sanofi Canada President and CEO, Hugh O'Neill (centre right) and members of Sanofi's Oncology Team celebrate the collaboration.
Image with caption: "Sanofi Canada is supporting a five-year study on radiation therapy and prostate cancer. Dr. Tamim Niazi (centre left), of the Quebec Radiation Oncology GU Group and the JGH, is the lead researcher. Sanofi Canada President and CEO, Hugh O'Neill (centre right) and members of Sanofi's Oncology Team celebrate the collaboration. (CNW Group/SANOFI CANADA)". Image available at: http://photos.newswire.ca/images/download/20120426_C9224_PHOTO_EN_12750.jpg
About Sanofi Sanofi is an R&D driven, AI-powered biopharma company committed to improving people's lives and delivering compelling growth. We apply our deep understanding of the immune system to invent medicines and vaccines that treat and protect millions of people around...
Also from this source
Share this article